Downregulation of both p21/Cip1 and p27/Kip1 produces a more aggressive prostate cancer phenotype.

作者: Srirupa Roy , Rana P. Singh , Chapla Agarwal , Sunitha Siriwardana , Robert A. Sclafani

DOI: 10.4161/CC.7.12.6024

关键词:

摘要: Roles of cyclin dependent kinase inhibitors, p21/Cip1 (p21) and p27/Kip1 (p27) in prostate cancer (PCa) progression is still not clear. Lower p27 protein expression PCa tissues often associated with poor prognosis, but prognostic significance p21 controversial. Herein, we investigated the role these molecules determining growth characteristics. We generated human DU145 cell variants knocked down levels (DU-p21) or (DU-p27), both (DU-p21+p27) via retroviral transduction respective shRNAs compared their various characteristics empty vector-transduced (DU-EV) cells vitro as well vivo. Knocking either did show any significant change doubling time, clonogenicity cycle cells, simultaneous knock-down significantly enhanced parameters. In athymic mice, DU-p21+p27 tumors showed higher rate than comparable DU-EV, DU-p21 DU-p27 tumors. Concurrently, had proliferation rate, showing 54% 48% increase proliferating nuclear antigen (PCNA) Ki-67-positive respectively, to DU-EV also microvessel density increased vascular endothelial factor (VEGF). Proliferation angiogenic status was Both vivo results implicate that have compensatory roles advanced ablation down-modulation essentially enhances aggressive carcinoma phenotype.

参考文章(31)
M Shiohara, WS el-Deiry, M Wada, T Nakamaki, S Takeuchi, R Yang, DL Chen, B Vogelstein, HP Koeffler, Absence of WAF1 Mutations in a Variety of Human Malignancies Blood. ,vol. 84, pp. 3781- 3784 ,(1994) , 10.1182/BLOOD.V84.11.3781.BLOODJOURNAL84113781
Matthew L. Fero, Erin Randel, Kay E. Gurley, James M. Roberts, Christopher J. Kemp, The murine gene p27Kip1 is haplo-insufficient for tumour suppression Nature. ,vol. 396, pp. 177- 180 ,(1998) , 10.1038/24179
Timothy J. Jorgensen, Ellen K. Wittmack, Hui Tian, p21WAF1/CIP1 Antisense Therapy Radiosensitizes Human Colon Cancer by Converting Growth Arrest to Apoptosis Cancer Research. ,vol. 60, pp. 679- 684 ,(2000)
A. Gotoh, T. Shirakawa, Y. Wada, M. Fujisawa, H. Okada, S. Kamidono, K. Hamada, The growth inhibitory effect of p21 adenovirus on androgen-dependent and -independent human prostate cancer cells BJU International. ,vol. 92, pp. 314- 318 ,(2003) , 10.1046/J.1464-410X.2003.04318.X
Jérôme Rigaud, Rabi Tiguert, Marc Decobert, Hélène Hovington, Eva Latulippe, Jacques Laverdiere, Hélène Larue, Louis Lacombe, Yves Fradet, Expression of p21 cell cycle protein is an independent predictor of response to salvage radiotherapy after radical prostatectomy. The Prostate. ,vol. 58, pp. 269- 276 ,(2004) , 10.1002/PROS.10329
BASAK DOGANAVSARGIL, ADNAN SIMSIR, HAYAL BOYACIOGLU, CAG CAL, MINE HEKIMGIL, A comparison of p21 and p27 immunoexpression in benign glands, prostatic intraepithelial neoplasia and prostate adenocarcinoma. BJUI. ,vol. 97, pp. 644- 648 ,(2006) , 10.1111/J.1464-410X.2006.06054.X
Jiyong Liang, Judit Zubovitz, Teresa Petrocelli, Rouslan Kotchetkov, Michael K. Connor, Kathy Han, Jin-Hwa Lee, Sandra Ciarallo, Charles Catzavelos, Richard Beniston, Edmee Franssen, Joyce M. Slingerland, PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest Nature Medicine. ,vol. 8, pp. 1153- 1160 ,(2002) , 10.1038/NM761
Charlie D Chen, Derek S Welsbie, Chris Tran, Sung Hee Baek, Randy Chen, Robert Vessella, Michael G Rosenfeld, Charles L Sawyers, Molecular determinants of resistance to antiandrogen therapy Nature Medicine. ,vol. 10, pp. 33- 39 ,(2004) , 10.1038/NM972
Timothy K. MacLachlan, Nianli Sang, Antonio Giordano, Cyclins, cyclin-dependent kinases and cdk inhibitors: implications in cell cycle control and cancer. Critical Reviews in Eukaryotic Gene Expression. ,vol. 5, pp. 127- 156 ,(1995) , 10.1615/CRITREVEUKARGENEEXPR.V5.I2.20